Arrowstreet Capital Limited Partnership purchased a new position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 193,096 shares of the company's stock, valued at approximately $1,549,000. Arrowstreet Capital Limited Partnership owned about 0.50% of Viemed Healthcare as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. National Bank of Canada FI boosted its holdings in shares of Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company's stock worth $25,000 after purchasing an additional 1,596 shares during the last quarter. R Squared Ltd acquired a new position in shares of Viemed Healthcare during the 4th quarter valued at about $41,000. Walleye Capital LLC purchased a new position in shares of Viemed Healthcare during the 3rd quarter worth about $87,000. EntryPoint Capital LLC acquired a new stake in shares of Viemed Healthcare in the fourth quarter worth approximately $92,000. Finally, Prudential Financial Inc. purchased a new stake in Viemed Healthcare in the fourth quarter valued at approximately $93,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.
Viemed Healthcare Trading Down 0.3 %
NASDAQ:VMD traded down $0.02 during trading hours on Wednesday, reaching $6.59. 6,336 shares of the company were exchanged, compared to its average volume of 136,638. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $9.81. The firm has a market cap of $260.45 million, a price-to-earnings ratio of 24.50 and a beta of 1.64. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The stock has a 50 day simple moving average of $7.41 and a 200 day simple moving average of $8.13.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories

Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.